Nucleid acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer

Details for Australian Patent Application No. 2002258626 (hide)

Owner Agensys, Inc.

Inventors Morrison, Karen; Afar, Daniel E. H.; Jakobovits, Aya; Faris, Mary; Morrison, Robert Kendall; Raitano, Arthur B.; Hubert, Rene S.; Challita-Eid, Pia M.; Ge, Wangmao

Agent FB Rice

Pub. Number AU-B-2002258626

PCT Pub. Number WO2002/083928

Priority 60/283,112 10.04.01 US; 60/286,630 25.04.01 US

Filing date 25 March 2002

Wipo publication date 28 October 2002

Acceptance publication date 18 January 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61M 36/14 (2006.01) Applying radioactive material to the body

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 2/00 (2006.01) Peptides of undefined number of amino acids

C07K 4/00 (2006.01) Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002258626

18 January 2007 Application Accepted

  Published as AU-B-2002258626

17 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258627-MACROLIDE EFFLUX GENETIC ASSEMBLY

2002258625-HIGH VOLTAGE, HIGH TEMPERATURE CAPACITOR STRUCTURES AND METHODS OF FABRICATING SAME